GlassScriptPhysician profile
Kyle P Brougham
NPI 1841829652
$26,585.05
in general payments reported to CMS, 2019-2025
10 companies · $24K in 2025
The $24K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,555 · 2023: $69.65 · 2024: $587 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $21K · Food and Beverage: $2,152 · Travel and Lodging: $1,504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $21,374.90 |
| Food and Beverage | $2,151.50 |
| Travel and Lodging | $1,503.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $22,005.30 | 2024-2025 | |
| Titan Surgical Group, LLC | $1,638.28 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $1,287.69 | 2025 | Comprehensive Shoulder System, Juggerknotless Soft Anchor |
| Stryker Corporation | $1,135.28 | 2022-2025 | Mako, Actishield, Iconix |
| Trimed, INC. | $159.75 | 2024 | |
| Depuy Synthes Sales INC. | $125.66 | 2025 | Teligen |
| Elite Orthopedics, LLC | $72.42 | 2025 | |
| Foundation Medical, LLC | $59.46 | 2025 | |
| Smith+Nephew, INC. | $51.52 | 2025 | Trigen Intertan, Maverick, Evos |
| Innovation Technologies INC | $49.69 | 2023 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Brougham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.